All articles published by MDPI are made immediately available worldwide under an open access license. No special
permission is required to reuse all or part of the article published by MDPI, including figures and tables. For
articles published under an open access Creative Common CC BY license, any part of the article may be reused without
permission provided that the original article is clearly cited. For more information, please refer to
https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature
Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for
future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive
positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world.
Editors select a small number of articles recently published in the journal that they believe will be particularly
interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the
most exciting work published in the various research areas of the journal.
The Current Oncology Young Investigator Award was established in 2021 to acknowledge the achievements of young investigators in the field of clinical oncology. Nominations are accepted from June each year to the end of February the following year, with the winners notified by the end of April the following year.
The Prize: – CHF 2000; – An electronic certificate; – A voucher to waive the Article Processing Charges (APCs) for one submission in the journal (subject to peer review)—valid for one year.
Number of Winners: One
Current Oncology Young Investigator Award
Nomination deadline: 28 February 2026
Winner announcement: 30 April 2026
– Must have completed oncology training and/or received their PhD no more than 10 years prior to 28 February 2026; – Must have produced ground-breaking research and made a significant contribution to the advancement of clinical oncology; – Must be nominated by senior scientists.
List of Documents for Nomination
– Detailed curriculum vitae, including an updated publication list and a list of the researcher’s own research grants; – Scanned copy of doctorate certificate; – Signed nomination letters from two established senior scientists.
Past Winners
Year:
Winner
Connie Le
University of Alberta
Award Committee
Prof. Shahid Ahmed
Chairman
Saskatoon Cancer Center, Saskatchewan Cancer Agency, University of Saskatchewan
Prof. Dr. Vittorio Gebbia
Prof. Dr. Katrin Scheinemann
Ostschweizer Kinderspital St. Gallen
Prof. Masayoshi Yamaguchi
University of Hawaii Cancer Center, University of Hawaii at Manoa
Dr. John Goffin
Juravinski Cancer Centre
Winner
Jonathan Loree
BCCA - Vancouver
Award Committee
Prof. Shahid Ahmed
Chairman
Saskatoon Cancer Center, Saskatchewan Cancer Agency, University of Saskatchewan
Prof. Masayoshi Yamaguchi
University of Hawaii Cancer Center, University of Hawaii at Manoa
Dr. Jörg Kleeff
Dr. Normand Blais
CHUM
Winner
Bishal Gyawali
Department of Oncology, Queen's University
Award Committee
Dr. Sharlene Gill
Chairman
BC Cancer
Dr. Stephanie Snow
Dalhousie University
Dr. Kirstin Perdrizet
William Osler Health System
Winner
Matteo Lambertini
University of Genova - IRCCS Policlinico San Martino Hospital
Award Committee
Dr. Sharlene Gill
Chairman
BC Cancer
Prof. Dr. Timm Denecke
Prof. Seungil Ro
Department of Physiology and Cell Biology, University of Nevada, Reno School of Medicine, 1664 N. Vir-ginia St., Reno, Nevada, 89557, USA.
Dr. Costantino Errani
IRCCS Istituto Ortopedico Rizzoli
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.